Georgia Kaiafa

ORCID: 0000-0001-8000-4500
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Chronic Lymphocytic Leukemia Research
  • Platelet Disorders and Treatments
  • Acute Myeloid Leukemia Research
  • Multiple Myeloma Research and Treatments
  • Lymphoma Diagnosis and Treatment
  • Hemoglobinopathies and Related Disorders
  • COVID-19 Clinical Research Studies
  • Blood groups and transfusion
  • Eosinophilic Disorders and Syndromes
  • Chronic Myeloid Leukemia Treatments
  • Autoimmune Bullous Skin Diseases
  • Complement system in diseases
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Diabetes Management and Research
  • Autoimmune and Inflammatory Disorders
  • Acute Ischemic Stroke Management
  • SARS-CoV-2 and COVID-19 Research
  • Acute Lymphoblastic Leukemia research
  • Long-Term Effects of COVID-19
  • Renal Diseases and Glomerulopathies
  • Diabetes and associated disorders
  • Hyperglycemia and glycemic control in critically ill and hospitalized patients
  • Iron Metabolism and Disorders
  • Systemic Lupus Erythematosus Research
  • Blood disorders and treatments

AHEPA University Hospital
2016-2025

Aristotle University of Thessaloniki
2016-2025

American Hellenic Educational Progressive Association
2025

International Hellenic University
2024

G. Papanikolaou General Hospital
2021-2022

Hellenic Airforce General Hospital
2021-2022

Democritus University of Thrace
2021

Alexander Technological Educational Institute of Thessaloniki
2019

Creative Commons
2015

Hellenic Agency for Local Development and Local Government
2008

<i>Introduction:</i> It has been shown recently that platelet indices like mean volume (MPV), size deviation width (PDW) and platelet-to-large-cell ratio (P-LCR) are helpful in the discrimination between hyperdestructive thrombocytopenia idiopathic thrombocytopenic purpura (ITP) hypoproductive (HT). The aim of study is to assess reliability these differentiation ITP from other thrombocytopenias. <i>Methods:</i> We recruited 134 patients (69 men, 65 women) who were...

10.1159/000135658 article EN Acta Haematologica 2008-01-01

The aim of this study is to evaluate the effects diabetes mellitus, hypertension and hypercholesterolemia on clinical presentation outcome Bell’s palsy. (comorbidity) group consisted 50 patients with palsy associated diabetes, hypertension, or hypercholesterolemia; control included 46 palsy, but without comorbid diseases. House–Brackmann grading system (I VI) was used in order assess initial final facial functions. Both groups were treated steroids antiviral agent acyclovir. mean severity...

10.3390/jcm10112357 article EN Journal of Clinical Medicine 2021-05-27

Systemic capillary leak syndrome (SCLS) constitutes a rare clinical entity. It is characterized by spontaneous, recurrent episodes of increased permeability, leading to double clinico-biological paradox: diffuse pitting edema with hypovolemia or hypovolemic shock, and hemoconcentration hypoalbuminemia, in the absence secondary causes for such abnormalities. Even though several theories have been proposed, exact pathophysiology SCLS remains unclear. We report herein case idiopathic...

10.7759/cureus.77261 article EN Cureus 2025-01-10

Abstract We have studied the efficacy and prognostic impact of novel agents in 50 primary plasma cell leukemia (pPCL) patients registered our database. Eighty percent were treated upfront with agent-based combinations; 40% underwent autologous stem transplantation (ASCT). Objective response rate was 76; 38% achieved at least very good partial (≥vgPR) this correlated significantly bortezomib-based therapy plus ASCT. At time evaluation, 40 had died. Early mortality (≤1 month) 6%. Median...

10.1038/s41408-018-0059-6 article EN cc-by Blood Cancer Journal 2018-03-09

Purpose: In the Emergency Departments (ED) current triage systems that are been implemented based completely on medical education and perception of each health professional who is in charge. On other hand, cutting-edge technology, Artificial Intelligence (AI) can be incorporated into healthcare systems, supporting professionals’ decisions, augmenting performance systems. The aim study to investigate efficiency AI support ED.Patients–Methods: included 332 patients from whom 23 different...

10.15388/amed.2023.30.1.2 article EN cc-by Acta medica Lituanica 2023-01-24

Abstract Objective Romiplostim has maintained long‐term platelet counts in patients with immune thrombocytopenia ( ITP ) for up to 5 yr clinical studies. This prospective observational study aimed describe romiplostim utilisation and outcomes European practice. Methods Adults primary who received routine care were eligible. Results Three‐hundred forty eligible analysis, of whom 299 (88%) completed the 2‐yr observation period. The median age was 62 yr, 43% aged ≥65 two‐thirds initiated before...

10.1111/ejh.12807 article EN cc-by-nc European Journal Of Haematology 2016-08-25

Background and Objectives: Thyroid disease has been associated with autoimmune disorders. As systemic lupus erythematosus (SLE) is a diverse manifestations spanning across all organ systems, the relationship of SLE thyroid disorders needs investigation. In particular, attracted interest research community. The aim was to evaluate disease. Materials Methods: A cohort 45 consecutive patients mean age 47.97 years (range 21-79 years) age- sex-matched controls were prospectively studied over...

10.3390/medicina59111911 article EN cc-by Medicina 2023-10-29

Prior studies have suggested that immune thrombotic thrombocytopenic purpura (iTTP) may display seasonal variation; however, methodologic limitations and sample sizes diminished the ability to perform a rigorous assessment. This 5-year retrospective study assessed epidemiology of iTTP determined whether it displays pattern. Patients with both initial relapsed (defined as disintegrin metalloprotease thrombospondin type motifs 13 activity <10%) from 24 tertiary centers in Australia, Canada,...

10.1002/ajh.27458 article EN cc-by American Journal of Hematology 2024-08-13

Given the limited real-world data of caplacizumab, our multicenter study was designed to assess safety and efficacy caplacizumab in immune thrombotic thrombocytopenic pupura (iTTP), compared historic controls. We have studied 70 patients: 23 47 control group. Plasma exchange applied all episodes except for two patients that denied plasma exchange. Rituximab as first-line treatment more common group control. Caplacizumab (10 mg daily) given at a median on day 7 (1–43) from initial diagnosis...

10.3389/fmed.2023.1226114 article EN cc-by Frontiers in Medicine 2023-10-11
Coming Soon ...